Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Breast Surgery · Idiopathic Granulomatous Mastitis

Choosing Your Path: Treatment Strategies for IGM

At a Glance

Idiopathic Granulomatous Mastitis (IGM) is a rare breast condition often successfully managed without surgery. Common treatments include observation, corticosteroids, methotrexate, or targeted antibiotics, with surgery typically reserved as a last resort due to scarring and recurrence risks.

Because Idiopathic Granulomatous Mastitis (IGM) is rare, there is no single “gold standard” treatment protocol [1][2]. This often means that a doctor who is not familiar with IGM may rush to suggest aggressive surgery, even though modern research shows that medical management or even careful observation can be highly effective [3][4]. Successful treatment often requires a multidisciplinary approach, involving breast specialists, rheumatologists, and sometimes infectious disease experts [2].

Your Treatment Options

Most doctors now prefer to start with the least invasive options possible. Your plan may include one or more of the following:

  1. Observation (“Watch and Wait”):
    IGM is a self-limiting condition, meaning it can eventually resolve on its own without aggressive intervention [5]. For patients with mild pain and limited inflammation, simply monitoring the condition while managing symptoms is a safe and recognized first-line strategy [4][6]. Be aware that it may take several months to a year for symptoms to fully resolve on their own [4].

  2. Corticosteroids:
    Steroids like prednisolone (or prednisone) are the most common first-line medical treatments [7]. They work by calming the overactive immune response in the breast [8].

    • Important Side Effects: Long-term use requires monitoring for systemic side effects like bone density loss, weight gain, and mood changes [9].
    • The Taper: To prevent the inflammation from returning (relapse) and minimize side effects, steroids are usually started at a higher dose and then slowly reduced (tapered) over about 3 months [10][11].

  3. Immunosuppressants (Methotrexate):
    If IGM is resistant to steroids or if you cannot tolerate the side effects of long-term prednisone, your doctor may suggest methotrexate [12][13]. This is known as a “steroid-sparing agent” because it allows you to lower the steroid dose while keeping the inflammation under control [12][14].

    • Critical Safety Warning: Methotrexate is highly teratogenic, meaning it can cause severe birth defects. Strict, reliable birth control is absolutely required while taking this medication [12]. Your liver function and blood counts will also need to be monitored regularly.

  4. Antibiotics (for CNGM):
    If your biopsy shows the Cystic Neutrophilic (CNGM) subtype, you may be prescribed a long course of antibiotics to target Corynebacterium [15]. These bacteria are often resistant to standard penicillins, so doctors typically use “lipophilic” antibiotics (which can penetrate the fatty tissue of the breast) like clarithromycin or rifampicin [15].

  5. Treating Hyperprolactinemia:
    If blood tests show you have high levels of prolactin (the milk-producing hormone), your doctor may prescribe medications like bromocriptine to lower these levels, which has been shown to help IGM resolve [16].

  6. Surgery and Drainage:
    While surgeons once performed wide excisions (removing a large area of tissue) for IGM, this is now often a last resort. Surgery can lead to significant scarring and, surprisingly, has a high recurrence rate because it is difficult for a surgeon to see exactly where the microscopic inflammation ends [3][17]. More commonly, a doctor might use a small needle or incision to drain a painful abscess to provide quick relief rather than removing breast tissue [18][19].

The Challenge of Recurrence

It is important to know that IGM can be “stubborn.” Recurrence—where the inflammation comes back after treatment—is a recognized challenge regardless of whether you choose medicine or surgery [1][20]. The presence of “residual disease” (small amounts of inflammation left behind) is the biggest risk factor for a flare-up [17]. This is why a slow, careful taper of medication and consistent follow-up appointments are critical to your long-term recovery.

Return to Home

Common questions in this guide

Can IGM go away on its own without treatment?
Yes, IGM is a self-limiting condition, meaning it can eventually resolve on its own. For mild cases, doctors often recommend an observation or 'watch and wait' approach to see if symptoms improve over several months to a year while managing pain.
What medications are used to treat idiopathic granulomatous mastitis?
Doctors often prescribe corticosteroids, such as prednisolone, as a first-line treatment to calm breast inflammation. If steroids are ineffective or cause severe side effects over time, immunosuppressants like methotrexate may be used instead.
Why do doctors try to avoid surgery for IGM?
Surgery, such as wide excision, can lead to significant breast scarring and actually has a high rate of the inflammation returning. Because it is hard to see where microscopic inflammation ends, doctors now prefer less invasive methods like medication or simple abscess drainage.
What is the treatment for the CNGM subtype?
If your biopsy shows Cystic Neutrophilic Granulomatous Mastitis (CNGM), a long course of specific antibiotics is typically prescribed. Doctors use lipophilic antibiotics like clarithromycin or rifampicin because they can penetrate breast tissue and target the Corynebacterium causing the issue.
Why is strict birth control necessary when taking methotrexate for IGM?
Methotrexate is highly teratogenic, meaning it can cause severe birth defects. Strict, reliable birth control is absolutely required to protect against these risks while using this medication to manage your IGM.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my case considered mild enough for an 'observation only' approach?
  2. 2.If we use corticosteroids, what is the planned tapering schedule to help prevent a relapse?
  3. 3.If we are considering methotrexate, what forms of birth control are recommended?
  4. 4.If I have the CNGM subtype, which specific antibiotics are most effective against the bacteria found in my biopsy?
  5. 5.Before we consider aggressive surgery, can we discuss the risk of recurrence and potential scarring compared to medical management?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Granulomatous lobular mastitis: Clinical update and case study.

    Brennan ME, Morgan M, Heilat GB, Kanesalingam K

    Australian journal of general practice 2020; (49(1-2)):44-47 doi:10.31128/AJGP-08-19-5042.

    PMID: 32008263
  2. 2

    Idiopathic granulomatous mastitis: case series and clinical review.

    Nguyen MH, Molland JG, Kennedy S, et al.

    Internal medicine journal 2021; (51(11)):1791-1797 doi:10.1111/imj.15112.

    PMID: 34713960
  3. 3

    Is surgical excision necessary for the treatment of Granulomatous lobular mastitis?

    Shin YD, Park SS, Song YJ, et al.

    BMC women's health 2017; (17(1)):49 doi:10.1186/s12905-017-0412-0.

    PMID: 28738795
  4. 4

    Granulomatous lobular mastitis.

    Zhou F, Yu LX, Ma ZB, Yu ZG

    Chronic diseases and translational medicine 2016; (2(1)):17-21 doi:10.1016/j.cdtm.2016.02.004.

    PMID: 29063020
  5. 5

    Re-evaluating if observation continues to be the best management of idiopathic granulomatous mastitis.

    Davis J, Cocco D, Matz S, et al.

    Surgery 2019; (166(6)):1176-1180 doi:10.1016/j.surg.2019.06.030.

    PMID: 31400951
  6. 6

    Granulomatous mastitis, watch and wait is a good option.

    Çetinkaya G, Kozan R, Emral AC, Tezel E

    Irish journal of medical science 2021; (190(3)):1117-1122 doi:10.1007/s11845-020-02406-0.

    PMID: 33078264
  7. 7

    The effect of corticosteroid treatment on bilateral idiopathic granulomatous mastitis.

    Çiftci F, Abdurrahman İ, Tatar Z

    Turkish journal of surgery 2017; (33(2)):113-115 doi:10.5152/UCD.2015.2950.

    PMID: 28740962
  8. 8

    Granulomatous Mastitis: A Ten-Year Experience at a University Hospital.

    Korkut E, Akcay MN, Karadeniz E, et al.

    The Eurasian journal of medicine 2015; (47(3)):165-73 doi:10.5152/eurasianjmed.2015.118.

    PMID: 26644764
  9. 9

    Variability in Clinical Response to Steroids in Granulomatous Mastitis: A Report of Two Cases.

    Corona-López KV, Sánchez-Romero M, Fernández-Rodríguez VB, et al.

    Cureus 2025; (17(10)):e93940 doi:10.7759/cureus.93940.

    PMID: 41200645
  10. 10

    Optimal Timing for Corticosteroid Therapy in Idiopathic Granulomatous Mastitis: A Retrospective Analysis Highlighting Early Intervention Efficacy.

    Wang P, Sun JZ, Fang HY, et al.

    Journal of inflammation research 2024; (17()):9617-9624 doi:10.2147/JIR.S498018.

    PMID: 39618926
  11. 11

    Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience.

    Esmaeil NK, Salih AM, Pshtiwan LRA, et al.

    Breast care (Basel, Switzerland) 2023; (18(4)):231-238 doi:10.1159/000529647.

    PMID: 37766742
  12. 12

    Efficacy and Tolerability of Methotrexate for Idiopathic Granulomatous Mastitis: A Systematic Review and Meta-Analysis.

    Han Y, Shi L, Zhang Y

    The breast journal 2026; (2026()):6710172 doi:10.1155/tbj/6710172.

    PMID: 41694557
  13. 13

    Impact of methotrexate monotherapy in patients with idiopathic granulomatous mastitis.

    Kaya MN, Tekgöz E, Çolak S, et al.

    Postgraduate medicine 2025; (137(5)):404-407 doi:10.1080/00325481.2025.2502322.

    PMID: 40323325
  14. 14

    Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial.

    Shojaeian F, Haghighat S, Abbasvandi F, et al.

    Journal of the American College of Surgeons 2024; (238(6)):1153-1165 doi:10.1097/XCS.0000000000001046.

    PMID: 38372343
  15. 15

    Idiopathic granulomatous mastitis: a 5-year retrospective review of cases in a tertiary centre in Dublin, Ireland.

    Houlihan E, Ryan K, Mannion J, et al.

    Journal of clinical pathology 2024; (77(12)):835-841 doi:10.1136/jcp-2023-209028.

    PMID: 37699697
  16. 16

    Gynecomastia with rare granulomatous lobular mastitis: a case report and literature review.

    Yin L, Agyekum EA, Zhang Q, et al.

    The Journal of international medical research 2022; (50(1)):3000605221075815 doi:10.1177/03000605221075815.

    PMID: 35098766
  17. 17

    Treatment of Granulomatous Mastitis With Steroids: Should the Decision to End the Treatment be Made Radiologically?

    Çetin K, Sıkar HE, Feratoğlu F, et al.

    European journal of breast health 2024; (20(1)):25-30 doi:10.4274/ejbh.galenos.2023.2023-9-2.

    PMID: 38187102
  18. 18

    A Case of Cystic Neutrophilic Granulomatous Mastitis in Which Mycobacteroides abscessus Was Detected.

    Yamazaki H, Ito Y, Goto K, Kasami M

    Surgical case reports 2025; (11(1)) doi:10.70352/scrj.cr.24-0115.

    PMID: 40008368
  19. 19

    Idiopathic granulomatous mastitis: experience at a New York hospital.

    Bhattarai P, Srinivasan A, Valenzuela CD, et al.

    Annals of the Royal College of Surgeons of England 2022; (104(7)):543-547 doi:10.1308/rcsann.2021.0239.

    PMID: 34812662
  20. 20

    Idiopathic granulomatous mastitis: Looking for the most effective therapy with the least side effects according to the severity of the disease in 374 patients in Iran.

    Kaviani A, Vasigh M, Omranipour R, et al.

    The breast journal 2019; (25(4)):672-677 doi:10.1111/tbj.13300.

    PMID: 31087459

This page provides educational information on IGM treatment strategies. It is not intended as medical advice; always discuss your specific case, medication side effects, and surgical risks with your breast specialist or rheumatologist.

Get notified when new evidence is published on Granulomatous mastitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.